TCL Archive NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate October 22, 1993
TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive Brandt Tells NIK There May Be No Exceptions To DRG Regulations, Maybe a Few At Comprehensive Centers June 24, 1983
